Abstract
In 2008, the European large -joint reconstructive implant market, comprising
hip and knee implants sold in Germany, the UK, Italy, and France, was valued
at over $2.3 billion
Revenue growth over the forecast period will be driven by a rise in procedure
volumes propelled by a steady increase in the aging population - a group more
susceptible to age -related joint conditions - along with the continued
surgeon and patient adoption of relatively higher -priced devices like
cementless and revision hip and knee implants
|